Results 231 to 240 of about 712,808 (414)
Role for monocyte-macrophage-derived colony-stimulating factor and prostaglandin E in the positive and negative feedback control of myeloid stem cell proliferation [PDF]
JI Kurland+4 more
openalex +1 more source
Exosome‐based nanoparticles (GC‐Exo‐CD16Ab) are designed to deliver glucocorticoids (GC) specifically to decidual CD16+ NK cells and macrophages. This targeted delivery effectively suppresses the cytotoxicity of decidual NK cells, inhibits M1 macrophage polarization, and modulates the decidual microenvironment.
Linlin Wang+17 more
wiley +1 more source
Introduction: Exposure to the microgravity environment could cause human physiological abnormalities that include fluid shift, anemia, osteoporosis, immunosuppression, etc. Monocytes and macrophages are important components of the immune system and could
Jiawei Yang, Wanlin Xing, Chongzhen Wang
doaj
Rickettsiose des monocytes observée chez le porc au Sénégal
M. Rioche, P. Bourdin
openalex +2 more sources
THE INTERACTION BETWEEN HUMAN MONOCYTES AND RED CELLS [PDF]
Neil Abramson+3 more
openalex +1 more source
AAV2.7m8 serotype combined with the gfaABC1D promoter targets infection of supporting cells (SCs). AAV2.7m8‐gfaABC1D‐Gjb2 administration to mice results in excessive immune responses. The combination of AAV2.7m8‐gfaABC1D‐Gjb2 with dexamethasone (DEX) shows a synergistic effect and enhances the gene therapy effect in a conditional Cx26 null mice model ...
Xiaohui Wang+8 more
wiley +1 more source
Editorial: Monocyte heterogeneity and plasticity
Heather J. Medbury+5 more
doaj +1 more source
Morphological Change of Monocytes Phagocytosed Quartz with Different Surface
H. Sakabe+3 more
openalex +2 more sources
A GRP78 nanobody‐directed immunotoxin suppresses cancer progression and metastasis by enhancing antitumor immunity via STING pathway activation, offering a pan‐cancer‐targeted approach and immunotherapy combination strategy. Abstract The lack of targetable antigens poses a significant challenge in developing effective cancer‐targeted therapies.
Huifang Wang+16 more
wiley +1 more source